Further, CRC patients with increased expression of METTL3 (Fig. 8L), RRM2B (Fig. 8M), OPA1 (Fig. 8N) and IGF2BP2 (Fig. S8G) showed reduced overall survival (OS). Here, OPA1 is linked to colorectal carcinoma.